Cardiology

Oct
17

Live Q&A: Keeping the Beat: Screening and Management of High-Risk Patients with Non-Valvular Atrial Fibrillation

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, projected to affect 12 million Americans by 2030. However, a significant number of AF cases, particularly non-valvular atrial fibrillation (NVAF) remain undiagnosed, putting patients at risk for severe cardiovascular (CV) complications, including increased risk of stroke. It is imperative that clinicians identify the symptomatology of AF and effectively diagnose NVAF, as these complications can potentially be avoided by increased screening and guideline-directed anticoagulation treatment. Unfortunately, despite the fact that both opportunistic and systematic screening have been shown to be effective in detecting NVAF, clinicians often lack knowledge of the available tools and strategies for implementing it, particularly in primary care settings.

This live question-and-answer session is your opportunity to ask our faculty your questions based on the CME Outfitters Live webcast that took place on October 7, 2020.

Read More
By Tom Meyers |
DETAIL
Jan
24

Sealing the Gaps in Non-Valvular Atrial Fibrillation Care: Use of Digital Tools to Optimize Treatment and Reduce Costs

For more information – Click Here  Questions about this activity? Call us at 877.CME.PROS(877.263.7767). This document was last modified on: 01/24/2019 10:38:52 TV4-097-110218-90

Read More
DETAIL
Jan
24
Jan
24
Jan
24
Nov
02